Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Audinot, V' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 54 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Audinot, V; Newman-Tancredi, A; Cussac, D; Millan, MJ
      Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT1D receptors

      NEUROPSYCHOPHARMACOLOGY
    2. Coge, F; Guenin, SP; Audinot, V; Renouard-Try, A; Beauverger, P; Macia, C; Ouvry, C; Nagel, N; Rique, H; Boutin, JA; Galizzi, JP
      Genomic organization and characterization of splice variants of the human histamine H-3 receptor

      BIOCHEMICAL JOURNAL
    3. Audinot, V; Newman-Tancredi, A; Millan, MJ
      Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP gamma S versus [S-35]-GTP gamma S binding isotherms

      NEUROPHARMACOLOGY
    4. Rodriguez, M; Beauverger, P; Naime, I; Rique, H; Ouvry, C; Souchaud, S; Dromaint, S; Nagel, N; Suply, T; Audinot, V; Boutin, JA; Galizzi, JP
      Cloning and molecular characterization of the novel human melanin-concentrating hormone receptor MCH2

      MOLECULAR PHARMACOLOGY
    5. Suply, T; Della Zuana, O; Audinot, V; Rodriguez, M; Beauverger, P; Duhault, J; Canet, E; Galizzi, JP; Nahon, JL; Levens, N; Boutin, JA
      SLC-1 receptor mediates effect of melanin-concentrating hormone on feedingbehavior in rat: A structure-activity study

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. Millan, MJ; Cussac, D; Milligan, G; Carr, C; Audinot, V; Gobert, A; Lejeune, F; Rivet, JM; Brocco, M; Duqueyroix, D; Nicolas, JP; Boutin, JA; Newman-Tancredi, A
      Antiparkinsonian agent piribedil displays antagonist properties at native,rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    7. Cordi, AA; Berque-Bestel, I; Persigand, T; Lacoste, JM; Newman-Tancredi, A; Audinot, V; Millan, MJ
      Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor properties

      JOURNAL OF MEDICINAL CHEMISTRY
    8. Audinot, V; Beauverger, P; Lahaye, C; Suply, T; Rodriguez, M; Ouvry, C; Lamamy, V; Imbert, J; Rique, H; Nahon, JL; Galizzi, JP; Canet, E; Levens, N; Fauchere, JL; Boutin, JA
      Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide ligands at SLC-1, the human MCH receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    9. Audinot, V; Lahaye, C; Suply, T; Beauverger, P; Rodriguez, M; Galizzi, JP; Fauchere, JL; Boutin, JA
      [I-125]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor

      BRITISH JOURNAL OF PHARMACOLOGY
    10. Yang, DL; Kefi, S; Audinot, V; Millan, MJ; Langlois, M
      Benzamides derived from 1,2-diaminocyclopropane as novel ligands for humanD-2 and D-3 dopamine receptors

      BIOORGANIC & MEDICINAL CHEMISTRY
    11. Millan, MJ; Newman-Tancredi, A; Audinot, V; Cussac, D; Lejeune, F; Nicolas, JP; Coge, F; Galizzi, JP; Boutin, JA; Rivet, JM; Dekeyne, A; Gobert, A
      Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT1B, 5-HT1D and dopamine D-2 and D-3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

      SYNAPSE
    12. Morris, BJ; Newman-Tancredi, A; Audinot, V; Simpson, CS; Millan, MJ
      Activation of dopamine D-3 receptors induces c-fos expression in primary cultures of rat striatal neurons

      JOURNAL OF NEUROSCIENCE RESEARCH
    13. Newman-Tancredi, A; Audinot, V; Moreira, C; Verriele, L; Millan, MJ
      Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT1B receptor/G-protein stoichiometry

      MOLECULAR PHARMACOLOGY
    14. Millan, MJ; Dekeyne, A; Newman-Tancredi, A; Cussac, D; Audinot, V; Milligan, G; Duqueyroix, D; Girardon, S; Mullot, J; Boutin, JA; Nicolas, JP; Renouard-Try, A; Lacoste, JM; Cordi, A
      S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    15. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Dubuffet, T; Lavielle, G
      S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    16. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Adhumeau, A; Brocco, M; Nicolas, JP; Boutin, JA; Despaux, N; Peglion, JL
      S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    17. Millan, MJ; Brocco, M; Rivet, JM; Audinot, V; Newman-Tancredi, A; Maiofiss, L; Queriaux, S; Despaux, N; Peglion, JL; Dekeyne, A
      S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine,and 11 other antipsychotic agents

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    18. Millan, MJ; Audinot, V; Honore, P; Bervoets, K; Veiga, S; Brocco, M
      Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    19. Dubuffet, T; Newman-Tancredi, A; Cussac, D; Audinot, V; Loutz, A; Millan, MJ; Lavielle, G
      Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D-3 receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    20. Cordi, A; Lacoste, JM; Audinot, V; Millan, M
      Design, synthesis and structure-activity relationships of novel strychnine-insensitive glycine receptor ligands

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    21. Millan, MJ; Brocco, M; Gobert, A; Joly, F; Bervoets, K; Rivet, JM; Newman-Tancredi, A; Audinot, V; Maurel, S
      Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat

      EUROPEAN JOURNAL OF NEUROSCIENCE
    22. Millan, MJ; Gobert, A; Audinot, V; Dekeyne, A; Newman-Tancredi, A
      Inverse agonists and serotonergic transmission: From recombinant, human serotonin (5-HT)(1B) receptors to G-protein coupling and function in corticolimbic structures in vivo

      NEUROPSYCHOPHARMACOLOGY
    23. Newman-Tancredi, A; Cussac, D; Audinot, V; Millan, MJ
      Actions of roxindole at recombinant human dopamine D-2, D-3 and D-4 and serotonim 5-HT1A, 5-HT1B and 5-HT1D receptors

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    24. Newman-Tancredi, A; Cussac, D; Audinot, V; Pasteau, V; Gavaudan, S; Millan, MJ
      G protein activation by human dopamine D-3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5 '-O-(3-[S-35]thio)-triphosphate binding and antibody study

      MOLECULAR PHARMACOLOGY
    25. GOBERT A; RIVET JM; AUDINOT V; NEWMANTANCREDI A; CISTARELLI L; MILLAN MJ
      SIMULTANEOUS QUANTIFICATION OF SEROTONIN, DOPAMINE AND NORADRENALINE LEVELS IN SINGLE FRONTAL-CORTEX DIALYSATES OF FREELY-MOVING RATS REVEALS A COMPLEX PATTERN OF RECIPROCAL AUTO-MEDIATED AND HETERORECEPTOR-MEDIATED CONTROL OF RELEASE

      Neuroscience
    26. NEWMANTANCREDI A; NICOLAS JP; AUDINOT V; GAVAUDAN S; VERRIELE L; TOUZARD M; CHAPUT C; RICHARD N; MILLAN MJ
      ACTIONS OF ALPHA(2) ADRENOCEPTOR LIGANDS AT ALPHA(2A) AND 5-HT1A RECEPTORS - THE ANTAGONIST, ATIPAMEZOLE, AND THE AGONIST, DEXMEDETOMIDINE,ARE HIGHLY SELECTIVE FOR ALPHA(2A) ADRENOCEPTORS

      Naunyn-Schmiedeberg's archives of pharmacology
    27. MILLAN MJ; NEWMANTANCREDI A; BROCCO N; GOBERT A; LEJEUNE F; AUDINOT V; RIVET JM; SCHREIBER R; DEKEYNE A; SPEDDING M; NICOLAS JP; PEGLION JL
      S-18126 4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)PIPERAZIN-1-YL METHYL]INDAN-2-YL)), A POTENT, SELECTIVE AND COMPETITIVE ANTAGONIST AT DOPAMINE D-4 RECEPTORS - AN IN-VITRO AND IN-VIVO COMPARISON WITH L-745,870 YL]PIPERAZIN-1-YL)METHYL-1H-PYRROLO[2,3B]PYRIDINE) AND RACLOPRIDE

      The Journal of pharmacology and experimental therapeutics
    28. AUDINOT V; NEWMANTANCREDI A; GOBERT A; RIVET JM; BROCCO M; LEJEUNE F; GLUCK L; DESPOSTE I; BERVOETS K; DEKEYNE A; MILLAN MJ
      A COMPARATIVE IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL DOPAMINE D-3 RECEPTOR ANTAGONISTS (-S-14297, NAFADOTRIDE, GR-103,691 AND U-99194())

      The Journal of pharmacology and experimental therapeutics
    29. MILLAN MJ; GOBERT A; NEWMANTANCREDI A; AUDINOT V; LEJEUNE F; RIVET JM; CUSSAC D; NICOLAS JP; MULLER O; LAVIELLE G
      S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - I - RECEPTORIAL AND NEUROCHEMICAL PROFILE COMPARISON WITH CLOZAPINE AND HALOPERIDOL

      The Journal of pharmacology and experimental therapeutics
    30. NEWMANTANCREDI A; GAVAUDAN S; CONTE C; CHAPUT C; TOUZARD M; VERRIELE L; AUDINOT V; MILLAN MJ
      AGONIST AND ANTAGONIST ACTIONS OF ANTIPSYCHOTIC AGENTS AT 5-HT1A RECEPTORS - A [S-35] GTP-GAMMA-S BINDING STUDY

      European journal of pharmacology
    31. PEGLION JL; VIAN J; GOUMENT B; DESPAUX N; AUDINOT V; MILLAN MJ
      TETRACYCLIC ANALOGS OF [-S14297 - SYNTHESIS AND DETERMINATION OF AFFINITY AND SELECTIVITY AT CLONED HUMAN DOPAMINE D-3 VS D-2 RECEPTORS(])

      Bioorganic & medicinal chemistry letters
    32. MILLAN MJ; NEWMANTANCREDI A; RIVET JM; BROCCO M; LACROIX P; AUDINOT V; CISTARELLI L; GOBERT A
      S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .1. INTERACTION WITH CLONED HUMAN (H)5-HT1A, DOPAMINE HD(2) HD(3) AND H-ALPHA(2A)-ADRENERGIC RECEPTORS IN RELATION TO MODULATION OF CORTICAL MONOAMINE RELEASE AND ACTIVITY IN MODELS OF POTENTIAL ANTIDEPRESSANT ACTIVITY/

      The Journal of pharmacology and experimental therapeutics
    33. NEWMANTANCREDI A; AUDINOT V; CHAPUT C; VERRIELE L
      [S-35] GUANOSINE-5'-O-(3-THIO)TRIPHOSPHATE BINDING AS A MEASURE OF EFFICACY AT HUMAN RECOMBINANT DOPAMINE D-4.4 RECEPTORS - ACTIONS OF ANTIPARKINSONIAN AND ANTIPSYCHOTIC AGENTS

      The Journal of pharmacology and experimental therapeutics
    34. LEJEUNE F; NEWMANTANCREDI A; AUDINOT V; MILLAN MJ
      INTERACTIONS OF (-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN AND (-)-8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN AND 7-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN AT HUMAN (H)D-3, HD(2) AND H-SEROTONIN(1A) RECEPTORS AND THEIR MODULATION OF THE ACTIVITY OF SEROTONINERGIC AND DOPAMINERGIC-NEURONS IN RATS())

      The Journal of pharmacology and experimental therapeutics
    35. AUDINOT V; LOCHON S; NEWMANTANCREDI A; LAVIELLE G; MILLAN MJ
      BINDING PROFILE OF THE NOVEL 5-HT1B 1D RECEPTOR ANTAGONIST, [H-3] GR-125,743, IN GUINEA-PIG BRAIN - A COMPARISON WITH [H-3] 5-CARBOXAMIDOTRYPTAMINE/

      European journal of pharmacology
    36. MORRIS BJ; NEWMANTANCREDI A; AUDINOT V; SIMPSON CS; MILLAN MJ
      INDUCTION OF C-FOS EXPRESSION IN CULTURED RAT STRIATAL NEURONS BY ACTIVATION OF DOPAMINE D-3 RECEPTORS

      British Journal of Pharmacology
    37. NEWMANTANCREDI A; AUDINOT V; JACQUES V; PEGLION JL; MILLAN MJ
      [H-3](-14297 - A NOVEL, SELECTIVE RADIOLIGAND AT CLONED HUMAN DOPAMINE D-3 RECEPTORS()S)

      Neuropharmacology
    38. MILLAN MJ; PEGLION JL; VIAN J; RIVET JM; BROCCO M; GOBERT A; NEWMANTANCREDI A; DACQUET C; BERVOETS K; GIRARDON S; JACQUES V; CHAPUT C; AUDINOT V
      FUNCTIONAL CORRELATES OF DOPAMINE D-3 RECEPTOR ACTIVATION IN THE RAT IN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .1. ACTIVATION OF POSTSYNAPTIC D-3, RECEPTORS MEDIATES HYPOTHERMIA, WHEREAS BLOCKADE OF D-2 RECEPTORS ELICITS PROLACTIN SECRETION AND CATALEPSY())

      The Journal of pharmacology and experimental therapeutics
    39. GOBERT A; RIVET JM; AUDINOT V; CISTARELLI L; SPEDDING M; VIAN J; PEGLION JL; MILLAN MJ
      FUNCTIONAL CORRELATES OF DOPAMINE D-3, RECEPTOR ACTIVATION IN THE RATIN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .2. BOTH D-2 AND SILENT D-3 AUTORECEPTORS CONTROL SYNTHESIS AND RELEASEIN MESOLIMBIC, MESOCORTICAL AND NIGROSTRIATAL PATHWAYS())

      The Journal of pharmacology and experimental therapeutics
    40. GOBERT A; LEJEUNE F; RIVET JM; AUDINOT V; NEWMANTANCREDI A; MILLAN MJ
      MODULATION OF THE ACTIVITY OF CENTRAL SEROTONINERGIC NEURONS BY NOVELSEROTONIN(1A) RECEPTOR AGONISTS AND ANTAGONISTS - A COMPARISON TO ADRENERGIC AND DOPAMINERGIC-NEURONS IN RATS

      The Journal of pharmacology and experimental therapeutics
    41. MILLAN MJ; RIVET JM; AUDINOT V; GOBERT A; LEJEUNE F; BROCCO M; NEWMANTANCREDI A; MAURELREMY S; BERVOETS K
      ANTAGONIST PROPERTIES OF LY-165,163 AT PRESYNAPTIC AND POSTSYNAPTIC DOPAMINE D-2, D-3, AND D-1 RECEPTORS - MODULATION OF AGONIST ACTIONS AT5-HT1A RECEPTORS IN-VIVO

      The Journal of pharmacology and experimental therapeutics
    42. SCHREIBER R; BROCCO M; AUDINOT V; GOBERT A; VEIGA S; MILLAN MJ
      (1-(2,5-DIMETHOXY-4 IODOPHENYL)-2-AMINOPROPANE)-INDUCED HEAD-TWITCHESIN THE RAT ARE MEDIATED BY 5-HYDROXYTRYPTAMINE (5-HT)(2A) RECEPTORS -MODULATION BY NOVEL 5-HT2A 2C ANTAGONISTS, D-1 ANTAGONISTS AND 5-HT1AAGONISTS/

      The Journal of pharmacology and experimental therapeutics
    43. PEGLION JL; CANTON H; BERVOETS K; AUDINOT V; BROCCO M; GOBERT A; LEMAROUILLEGIRARDON S; MILLAN MJ
      CHARACTERIZATION OF POTENT AND SELECTIVE ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS IN A SERIES OF N4-SUBSTITUTED ARYLPIPERAZINES

      Journal of medicinal chemistry
    44. MILLAN MJ; AUDINOT V; MELON C; NEWMANTANCREDI A
      EVIDENCE THAT DOPAMINE D-3 RECEPTORS PARTICIPATE IN CLOZAPINE-INDUCEDHYPOTHERMIA

      European journal of pharmacology
    45. MAURELREMY S; AUDINOT V; LEJEUNE F; BERVOETS K; MILLAN MJ
      BLOCKADE OF PHENCYCLIDINE-INDUCED HYPERLOCOMOTION IN RATS BY CLOZAPINE, MDL-100,907 AND OTHER ANTIPSYCHOTICS CORRELATES WITH AFFINITY AT 5-HT2A RECEPTORS

      British Journal of Pharmacology
    46. MILLAN MJ; AUDINOT V; BROCCO M; MAURELREMY S; JOLY F; NEWMANTANCREDI A; CANTON H; HAUTEFAYE P; SPEDDING M; MULLER O; LAVIELLE G
      S-16924 - A PYRROLIDINE-SUBSTITUTED BENZODIOXANE WITH HIGHER AFFINITYAT 5-HT1A 2A/2C THAN D2 RECEPTORS, AND AN ATYPICAL ANTIPSYCHOTIC PROFILE IN THE RAT/

      British Journal of Pharmacology
    47. MOREAU C; RASOLONJANAHARY R; AUDINOT V; KORDON C; ENJALBERT A
      ANGIOTENSIN-II EFFECTS ON 2ND-MESSENGERS INVOLVED IN PROLACTIN SECRETION ARE MEDIATED BY AT(1)-RECEPTOR IN ANTERIOR-PITUITARY-CELLS

      Molecular and cellular neurosciences
    48. MILLAN MJ; CANTON H; GOBERT A; LEJEUNE F; RIVET JM; BERVOETS K; BROCCO M; WIDDOWSON P; MENNINI T; AUDINOT V; HONORE P; RENOUARD A; LEMAROUILLEGIRARDON S; VERRIELE L; GRESSIER H; PEGLION JL
      NOVEL BENZODIOXOPIPERAZINES ACTING AS ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS AND AS AGONISTS AT 5-HT1A AUTORECEPTORS - A COMPARATIVE PHARMACOLOGICAL CHARACTERIZATION WITH PROPOSED 5-HT1A ANTAGONISTS

      The Journal of pharmacology and experimental therapeutics
    49. RIVET JM; AUDINOT V; GOBERT A; PEGLION JL; MILLAN MJ
      MODULATION OF MESOLIMBIC DOPAMINE RELEASE BY THE SELECTIVE DOPAMINE-D-3 RECEPTOR ANTAGONIST, (-S-14297())

      European journal of pharmacology
    50. MILLAN MJ; AUDINOT V; RIVET JM; GOBERT A; VIAN J; PROST JF; SPEDDING M; PEGLION JL
      S-14297, A NOVEL SELECTIVE LIGAND AT CLONED HUMAN DOPAMINE-D-3 RECEPTORS, BLOCKS 7-OH-DPAT-INDUCED HYPOTHERMIA IN RATS

      European journal of pharmacology
    51. LEJEUNE F; AUDINOT V; GOBERT A; RIVET JM; SPEDDING M; MILLAN MJ
      CLOZAPINE INHIBITS SEROTONINERGIC TRANSMISSION BY AN ACTION AT ALPHA(1)-ADRENOCEPTORS NOT AT 5-HT1A RECEPTORS

      European journal of pharmacology
    52. CUSSAC D; CACCAVELLI L; PELLEGRINI I; AUDINOT V; JAQUET P; ENJALBERT A
      MEMBRANE-RECEPTORS AND G-PROTEINS IN ANTE RIOR-PITUITARY-CELLS

      Comptes rendus des seances de la Societe de biologie et de ses filiales
    53. CANTON H; AUDINOT V; VERRIELE L; JACQUES V; MILLAN MJ
      ACTIONS OF ANTIPSYCHOTIC-DRUGS AT 5-HT1C AND 5-HT2 RECEPTORS - EVIDENCE FOR POTENT 5-HT1C RECEPTOR ANTAGONISM BY CLOZAPINE BUT NOT HALOPERIODOL BOTH IN-VITRO AND IN-VIVO

      Journal of neurochemistry
    54. CACCAVELLI L; CUSSAC D; PELLEGRINI I; AUDINOT V; JAQUET P; ENJALBERT A
      D2 DOPAMINERGIC RECEPTORS - NORMAL AND ABNORMAL TRANSDUCTION MECHANISMS

      Hormone research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/11/20 alle ore 03:16:27